Ashford Capital Management Inc has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $766 Million distributed in 101 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cellebrite Di Ltd. with a value of $40.8M, Ligand Pharmaceuticals Inc with a value of $33.3M, Axon Enterprise, Inc. with a value of $32.7M, Stone X Group Inc. with a value of $28.7M, and Vanguard Total Stock Market Et with a value of $28.3M.

Examining the 13F form we can see an increase of $32.8M in the current position value, from $733M to 766M.

Ashford Capital Management Inc is based out at Wilmington, DE

Below you can find more details about Ashford Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $766 Million
Technology: $215 Million
Healthcare: $122 Million
Financial Services: $102 Million
ETFs: $74.3 Million
Industrials: $72.1 Million
Consumer Cyclical: $57.3 Million
Real Estate: $53.4 Million
Communication Services: $33.7 Million
Other: $35.9 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 101
  • Current Value $766 Million
  • Prior Value $733 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 7 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 41 stocks
Track This Portfolio

Track Ashford Capital Management Inc Portfolio

Follow Ashford Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.